ENHERTU Plus Pertuzumab Approved in the U.S. for First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer ...
With office parties, cocktails with friends and end-of-year celebrations in full swing, many of us brace for hangovers without realising that festive drinking can have a real and often overlooked ...
December 2025 Enhertu granted Breakthrough Therapy Designation in the US as post-neoadjuvant therapy for patients with HER2-positive early breast cancer Tenth Breakthrough Therapy Designation for Astr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results